Caspase 9 Monoclonal Antibody(3-20)

This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein can undergo autoproteolytic processing and activation by the apoptosome, a protein complex of cytochrome c and the apoptotic peptidase activating factor 1; this step is thought to be one of the earliest in the caspase activation cascade. This protein is thought to play a central role in apoptosis and to be a tumor suppressor. Alternative splicing results in multiple transcript variants.

Introducing the CASPASE 9 Monoclonal Antibody (3-20), a cutting-edge scientific tool designed to revolutionize research in the field of apoptosis. This highly specific antibody is meticulously engineered to target and detect caspase 9, a key enzyme involved in the apoptotic pathway.

The CASPASE 9 Monoclonal Antibody (3-20) boasts exceptional sensitivity and selectivity, enabling researchers to accurately investigate the intricate mechanisms underlying programmed cell death. Its monoclonal nature ensures consistent and reproducible results, guaranteeing the reliability of experimental outcomes.

With its advanced formulation, this antibody offers unparalleled versatility, making it suitable for a wide range of applications, including immunohistochemistry, immunofluorescence, and western blotting. Its robust performance across various experimental techniques ensures optimal data acquisition and analysis.

Furthermore, the CASPASE 9 Monoclonal Antibody (3-20) is manufactured using state-of-the-art techniques and undergoes rigorous quality control measures to ensure utmost purity and functionality. Its exceptional stability and long shelf life make it an ideal choice for long-term research projects.

In summary, the CASPASE 9 Monoclonal Antibody (3-20) represents a breakthrough in apoptosis research, offering researchers an invaluable tool to unravel the complexities of programmed cell death. Its exceptional sensitivity, versatility, and reliability make it an indispensable asset for any laboratory seeking to advance their understanding of this fundamental biological process.